Longitudinal stability of anti-JC virus (JCV) antibody index over 2 years in multiple sclerosis (MS) patients treated with natalizumab in the ascend study

Authors
Category Primary study
JournalNeurology
Year 2019
This article has no abstract
Epistemonikos ID: ee30df7c8a07d70304ba15d412e82fd87d18ed19
First added on: Feb 11, 2025